Accenture Named a Leader in Worldwide Life Sciences R&D BPO Servicesby IDC MarketScape for Third Consecutive Time

Accenture (NYSE: ACN) has been named a Leader in an IDC Health Insights
IDC MarketScape vendor assessment covering business process outsourcing
(BPO) across the life sciences research and development (R&D) industry.
This is the third consecutive time Accenture
Life Sciences has achieved this prestigious ranking.

The report, “IDC
MarketScape: Worldwide Life Science R&D BPO 2018 Vendor Assessment”
(IDC #US42144618, June 2018), examines the current life sciences R&D BPO
landscape, including industry and market trends, comparing major vendors
against the criteria most important for life sciences companies to
consider when selecting a service provider.

Alan
Louie, Ph.D, research director for IDC Health Insights Life Sciences
practice, notes in his report, “Accenture has extensive experience
working with life science companies across all three sections of the
industry: pharmaceutical, biotech, and medical devices. Building on an
aggressive growth and acquisition strategy, Accenture has diversified
significantly beyond its traditional big pharma focus and has grown its
presence among emerging and mid-tier life science companies in recent
years. Relative to other vendors discussed in this study, and based on
feedback from multiple customer references, Accenture received high
marks for transparent integration into client teams, working as a vested
partner, and helping the client improve operational efficiencies across
a widening portfolio of efforts.”

Kevin
Julian, senior managing director in Accenture’s Life Sciences
practice, said, “This leadership positioning in the IDC MarketScape
emphasizes our focus on providing best-in-class solutions to top global
and emerging pharmaceutical, biotech and medical device companies. We’re
pleased to be recognized for the third consecutive time by IDC as a
high-quality BPO service provider, demonstrating the breadth of our
understanding of this dynamic industry across company-specific,
strategic and tactical levels.”

In naming Accenture Life Sciences as a Leader, the IDC MarketScape
looked at:

For the purposes of this analysis, IDC Health Insights divided potential
key measures for success into two primary categories: capabilities and
strategies. The assessment includes client references.

Click
here to learn more about Accenture’s Life Sciences practice and
the Accenture
Accelerated R&D Services.

About IDC MarketScape

IDC MarketScape vendor analysis model is designed to provide an overview
of the competitive fitness of ICT (information and communications
technology) suppliers in a given market. The research methodology
utilizes a rigorous scoring methodology based on both qualitative and
quantitative criteria that results in a single graphical illustration of
each vendor’s position within a given market. IDC MarketScape provides a
clear framework in which the product and service offerings, capabilities
and strategies, and current and future market success factors of IT and
telecommunications vendors can be meaningfully compared. The framework
also provides technology buyers with a 360-degree assessment of the
strengths and weaknesses of current and prospective vendors.

About Accenture

Accenture is a leading global professional services company, providing a
broad range of services and solutions in strategy, consulting, digital,
technology and operations. Combining unmatched experience and
specialized skills across more than 40 industries and all business
functions – underpinned by the world’s largest delivery network –
Accenture works at the intersection of business and technology to help
clients improve their performance and create sustainable value for their
stakeholders. With 449,000 people serving clients in more than 120
countries, Accenture drives innovation to improve the way the world
works and lives. Visit us at www.accenture.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180712005081/en/

Leave a Comment